Shan Herath

Shan Herath has a diverse work experience in the field of scientific research. Shan is currently working as a Senior Scientist at Quell Therapeutics since July 2021. Prior to this, they held the role of Senior Research Associate/Lab Manager at Royal Holloway, University of London for 8 years. Shan'sresponsibilities included researching gene therapy products and their impact on the immune response, as well as managing the lab operations and staff. Shan also worked as a Senior Research Associate at King's College, London and Imperial College, London from 2009 to 2013, where they focused on primary research involving HIV/SIV vaccine and assessing CD8+ T cell responses. Before that, Shan worked as a Research Associate at the Royal Veterinary College from 2004 to 2008, conducting research on the effect of E. coli LPS on bovine endometrial and ovarian cells. Shan'sroles involved project management, sample collection, and data analysis.

Shan Herath has a Ph.D in Immunology from Imperial College London. Shan also holds an M.Sc. in Immunology of Infectious Diseases from the London School of Hygiene and Tropical Medicine, University of London. Additionally, they have a B.Sc. in Genetics from Queen Mary and Westfield College, London.